The Response of Variant Histology Bladder Cancer to Intravesical Immunotherapy Compared to Conventional Cancer

BACKGROUND: High-grade urothelial carcinomas (UCs) often show foci of variant differentiation. There is limited information in the literature about the response of these variant urothelial tumors to immunotherapy with bacillus Calmette–Guerin (BCG). We compared the response, to treatment with BCG, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gofrit, Ofer N., Yutkin, Vladimir, Shapiro, Amos, Pizov, Galina, Zorn, Kevin C., Hidas, Guy, Gielchinsky, Ilan, Duvdevani, Mordechai, Landau, Ezekiel H., Pode, Dov
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791377/
https://www.ncbi.nlm.nih.gov/pubmed/27014622
http://dx.doi.org/10.3389/fonc.2016.00043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791377/
https://www.ncbi.nlm.nih.gov/pubmed/27014622
http://dx.doi.org/10.3389/fonc.2016.00043

Ejemplares similares